title: 9th International drug delivery technologies & deal-making summit.
abstract: SRI's 9th International drug delivery summit analysed the current position of drug delivery technologies within the pharmaceutical industry. The classical position of drug delivery as a tool in life cycle management is currently expanding into the primary formulations or even into enabling positions. Using drug delivery as a platform for drug development or redevelopment was recognised as a trend in the industry which is supported by the rapidly growing portion of drug delivery enhanced products already sold as well as by industry initiatives supporting future growth of the sector.
authors.affiliation: Novosom AG, Weinbergweg 22, D-06120 Halle, Germany. steffen.panzner@novosom.com
authors.forename: Steffen
authors.initials: S
authors.lastname: Panzner
authors.forename: Philip L
authors.initials: PL
authors.lastname: Smith
mesh_terms: D016503:Drug Delivery Systems / Q000191:economics / Q000639:trends*; D015195:Drug Design; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry; D013678:Technology, Pharmaceutical / Q000331:legislation & jurisprudence / Q000639:trends*
chemical_list: D004364:Pharmaceutical Preparations